Delivery Order SPE2DB22D3501-SPE2DB24FUM79
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,369.40, is for the supply of QSYMIA 15MG-92MG 30S, a prescription medication. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Qsymia 11.25 mg-69 mg capsules (30-count unit) with a firm fixed price ceiling value of $2,037.36. The order is scheduled for completion by August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded under an existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.00 to AmerisourceBergen Drug Corp for Qsymia 15mg-92mg in a 30-count supply, with an ultimate completion date of November 26, 2025. This non-competitive, firm fixed-price delivery order was issued on November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA....
- This federal contract award is a delivery order valued at $1,630.25, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of QSYMIA 3.75 MG-23 MG capsules in 30-count packages. The contract has a firm fixed price and an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $1,945.44 firm fixed-price delivery order for QSYMIA 11.25 mg-69 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The product...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,064.25 order is for the medication Qsymia 3.75 mg-23 mg capsules, with a completion date of March 6, 2024. Amerisourcebergen Drug Corporation, through its Corporate Office division in Conshohocken, Pennsylvania, regularly fulfills pharmaceutical and medical supply contracts for...
- The Defense Logistics Agency awarded a delivery order valued at $4,444.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 15 mg–92 mg capsules (30-count) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price delivery order utilizes no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,133.09 on September 18, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count). This is a firm fixed-price, non-set-aside contract with a completion date of September 19, 2025, and performance will be conducted at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,590.00 to AmerisourceBergen Drug Corp for QSYMIA 11.25mg-69mg tablets (30-count units) on December 17, 2025, with completion scheduled for December 18, 2025. This competitive award, which carries no set-aside designation, was issued under a firm fixed-price contract type and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. QSYMIA is a prescription weight-management medication...
- The Defense Logistics Agency awarded a $1,013.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUM79Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,221.29 delivery order is for the supply of 30 units of the prescription medication QSYMIA 3.75 MG-23 MG CAPSULE. The delivery order was awarded on February 8, 2024, with a completion date of February 9, 2024. This award is not set aside for any small business or socioeconomic program. It is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 2/8/24 |